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AM returned in March 2006 complaining of 2 weeks 
of watery diarrhoea and lower abdominal pain. He 
had no abdominal tenderness and no change in 
weight but was noted for the first time to have a 
palpable spleen. A presumptive diagnosis of Giardia 
lamblia was made and he was given tinidazole 2 g 
by mouth. Repeat stools showed only Hymenolepis 
nana, which may have been responsible for the 
presenting symptomatology in March,6 and he was 
given a repeat dose of praziquantel.7 Blood tests 
revealed a rising bilirubin and falling platelet count, 
and ultrasound demonstrated an 18 cm spleen. A 
computerised tomography (CT) scan confirmed portal 
hypertension with prominent portal veins presumed 
by the radiologist to be from ‘pipe stem cirrhosis’ 
due to the schistosomiasis. He was referred to the 
local teaching hospital where further tests showed a 
normal autoimmune screen, negative leishmaniasis 
immunofluorescent antibody, and no atypical cell 
populations on bone marrow. Endoscopy revealed 
‘sizeable oesophageal varices with high risk 
features’ which had not been evident on the scan. 
His abdominal symptoms settled with the tinidazole 
and praziquantel, his blood tests improved slightly 
(Table 1) and his spleen decreased in size to less than 
17 cm as measured by repeat ultrasound. 
Discussion
Schistosomiasis (bilharzia) infects humans when their 
skin comes into contact with fresh water contaminated 
with certain types of snails that act as the vector for 
the parasite. Hundreds of eggs are laid each day. These 
eggs hatch, infect water snails, which in turn release 
schistosomal cerciae into the water. The cerciae penetrate 
the skin and migrate through the tissues and vascular 
system of the definitive host.8 Humans are the definitive 
Case study
AM, 17 years of age, arrived in Adelaide with his family as a refugee from Sudan in August 2005. 
He had spent the previous 5 years in Kakuma refugee camp in northern Kenya where over 82 000 
people are living in an area of 25 km2 with limited safety, health facilities, food or sanitation.1 As 
part of an initial health assessment in Adelaide he was screened for illnesses endemic in Africa as 
well as for haemoglobinopathies, nutritional deficiencies, and torture and trauma issues. 
Abnormalities found were: a positive titre (1:640) for schistosomiasis antibody, eggs of 
Hymenolepis nana (dwarf tapeworm) in his stool, sickle cell trait (38.2% HbS), low platelets, low 
white cell count and high bilirubin (Table 1). He had no evidence of hepatitis B or C, no malaria, 
normal liver function tests, no lymphadenopathy and no other specific health concerns. He was 
treated with praziquantel (Biltricide) at a dose of 40 mg/kg in two divided doses (with food), 4 
hours apart.5 No follow up was arranged as he had no schistosome ova in his stools and cure 
rates are high using the recommended dose (Figure 1).5
In 2004–2005, approximately 13 000 refugees settled in Australia, 70% of them from Africa.1 Schistosomiasis is one of the 
many illnesses endemic in Africa and approximately 40% of refugees have been found to be infected by this parasite.2 It 
has the potential to cause serious morbidity and mortality in those who are infected and after malaria is the second most 
prevalent tropical disease worldwide.3 Australia is not known to have an appropriate snail vector and so schistosomiasis 
is unlikely to be a public health problem.4 This article presents a case that demonstrates one of the sequelae of 
schistosomiasis – pipe stem cirrhosis – with associated splenomegaly and oesophageal varices.
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host for the most common schistosomes seen 
in travellers from endemic countries and in 
refugees to Australia. Adult worm pairs are 
found ‘in copulo’ in venous complexes either 
in the bladder in the case of S. haematobium 
which causes urinary schistosomiasis, or in the 
portal venous plexuses surrounding the bowel 
in S. mansoni and S. japonicum which cause 
mainly gastrointestinal disease. 
 Schistosomiasis was introduced into South 
America when a local water snail proved to be 
a very efficient vector of S. mansoni brought 
into the continent with African slaves.9 There 
is an ever present fear of the introduction and 
establishment in natural water bodies in Australia 
of snails accidentally imported with fish or 
plants from abroad, or on the feet of migratory 
birds.4 The absence of evidence however does 
not necessarily equate to absence of disease 
and the increasing incidence of schistosomiasis 
worldwide remains a concern.
 Schistosomiasis is endemic in Africa, 
infecting some 200 million people.8 In 2001 
it was estimated that 1.7 million disability 
adjusted life years (DALYs) were lost, not 
including the subtle effects of chronic 
infection from early childhood on growth, 
development and education.10 It is the most 
common cause of ‘massive splenomegaly’ 
(spleen >10 cm), others being hyper-reactive 
malarial splenomegaly, lymphomas, visceral 
leishmaniasis, haemoglobinopathies, chronic 
myeloid leukaemia and myelofibrosis.3 
 Schistosomiasis is asymptomatic in up to 
80% of those infected, with tiredness being 
the most common symptom.11 It is the 
most common cause of portal hypertension 
worldwide,12 typically caused by S. mansoni 
and characterised by portal vein obstruction 
from intrahepatic periportal fibrosis, ‘Symmers 
pipe stem fibrosis’.12 Large numbers of eggs 
escaping from the lower mesenteric veins reach 
the periportal regions causing a granulomatous 
response leading to gradual occlusion of the 
intrahepatic portal veins. Schistosomal portal 
hypertension occurs in only a minority of 
those infected and is usually asymptomatic 
with normal liver function tests until very 
late in the course of the disease. The initial 
presentation, even in the young, may be with 
variceal bleeding. Co-infection with hepatitis B 
or hepatitis C and S. mansoni is associated with 
accelerated deterioration of hepatic function.12
 Praziquantel in a dose of 40 mg/kg in two 
divided doses is the recommended regimen.6,12 
It has minimal side effects but there may be 
some abdominal pain in those with heavy 
parasite loads. Resistance is rare and it is 
thought it may represent noncompliance, the 
invulnerability of immature worms, re-infection 
or the detection of dead eggs which may 
be passed in the stool for many months.5 In 
pregnant and lactating women praziquantel has 
Figure 1. Schistosomiasis follow up for recently arrived African refugees
•  Praziquantel 20 mg/kg stat 
and then a further 20 mg/kg 
4–6 hours later (with food)
•  Urinalysis – if dipstick 
positive for blood, urine 
microscopy for eggs 
(collect 12:00–15:00 pm)
• Stool positive for  
 schistosome eggs
•  Upper abdominal 
ultrasound
•  Repeat stool for eggs  
(x 3 specimens) 8 weeks 
after praziquantel – if 
positive, repeat praziquantel
•  If still excreting eggs 8 
weeks after second course 
of praziquantel, refer to  
infectious diseases clinic
•  Plain KUB X-ray
•  Refer to urologist for 
cystoscopy and genital 
evaluation
•  Repeat urine for eggs 
8 weeks after second 
course of praziquantel 
– if positive, repeat 
praziquantel
•  If still excreting eggs 
8 weeks after second 
course of praziquantel, 
refer to infectious 
diseases clinic
No further follow up
Stool positive for schistosome 
eggs (S. mansoni or 
intercalatum)
Urine positive for 
schistosome eggs  
(S. haematobium)
No schistosome 
eggs seen in stool 
or urine
No further follow up
NegativePositive
Ultrasound normal and 








No further follow up •   Look for other 
causes of fibrosis 
(HBV, HCV, alcohol, 
haemachromatosis)
•   Refer to hepatologist/
liver clinic
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not been shown to have any teratogenic effects, 
and in many circumstances it is deemed that the 
benefits outweigh the potential harm.8 When all 
worms are killed and egg production ceases, 
the granulomatous response to existing eggs 
subsides and associated hepatic changes and 
portal hypertension may significantly diminish or 
partially resolve over a period of months.8
 The main risks of S. mansoni liver disease 
are thrombocytopenia with its risk of bleeding; 
splenomegaly with the risk of trauma; and the 
development of oesophageal varices because 
of the portal hypertension.13 Splenectomy is 
unlikely to be part of the treatment as it has 
been shown to be of only limited benefit and 
carries many risks.13 If there is haemorrhage 
of varices and banding is unsuccessful or 
contraindicated, portosystemic shunts or one of 
the newer shunt procedures may be needed to 
reduce portal pressure.4
 The lack of subsidised payment for 
praziquantel on the Pharmaceutical Benefits 
Scheme (PBS) in Australia means that general 
practitioners need to refer patients to specialised 
refugee services or hospital for treatment. 
Schistosomiasis was not mentioned in the list 
of recommended investigations for the new 
Medical Benefits Schedule (MBS) item number 
714 for Health Assessments for Refugees,14 
but it is obviously important to be aware of this 
potentially severe disease in those who come 
from endemic areas. 
Conclusion
This case of schistosomiasis illustrates just one 
of the many asymptomatic ‘exotic’ illnesses 
that may have serious, long term implications 
if not detected and treated promptly and 
appropriately. As community GPs are now being 
encouraged to be the first point of contact 
for refugees, there needs to be support and 
education about diseases that are uncommon 
in Australia. Similarly, as the source countries 
for refugees vary, hospital doctors need to 
be conscious of the changing need for 
unusual tertiary investigations and treatments. 
Screening, treatment, and follow up and a high 
index of suspicion may prevent morbidity and 
mortality in patients such as refugees who 
settle in Australia. 
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Table 1. AM’s test results
  11/10/2005 8/3/2006 5/5/2006 6/7/2006
Platelets x109/L (150–400) 75 48 54 61
White cell count x109/L (4.00–11.00) 3.56 1.8 2.67 2.71
Bilirubin mcmol/L (6–24) 25 43 30 31
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